TBD-Biodiscovery is an independent Estonian company, founded in 2006 by private capital. Our business started with contract services and grew up to small scale API/HPAPI manufacturing and development of our own products portfolio which includes Ultrahigh grade D-Luciferin, fine chemicals and active ingredients.
Please see our presentation to find out more.
TBD-Biodiscovery also provides a number of contract services for biotech, pharma, drug development and agrochemical companies and has partners worldwide: European Union, Switzerland, United States, Israel and Russia.
TBD-Biodiscovery has certificate of GMP compliance to manufacture non-sterile active pharmaceutical ingredients by chemical synthesis and has successfully passed audits by customers and State Agency of Medicines.
2006 TBD-Biodiscovery is established by entrepreneurs and scientists.
2008 GMP compliance certificate is issued by State Agency of Medicines.
2010 Class D clean-room and first manufacturing unit is constructed.
2011 First batches of active ingredients produced.
2012 New premises for R&D and manufacturing (> 250 m2).
2013 TBD-Biodiscovery has customers worldwide (EU, Switzerland, US, Israel, Russia). Amrubicin semisynthetic technology is patented in the European Union. The company contributed to several EU-projects, organized through Enterprise Estonia (EU regional fund). TBD-Biodiscovery participates in the EU-project MABTOX, dedicated to development of next-generation Antibody-Toxin-Conjugates for cancer therapy.
2014 Additional separate GMP-facility for anticancers.